Optimal strategy for antiplatelet therapy after coronary drug-eluting stent implantation in high-risk "TWILIGHT-like" patients with diabetes mellitus

17 April 2021 (09:12 - 09:20)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Hao-Yu Wang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

5 More presentations in this session

Presentation thumbnail

Physical activity and sedentary behaviour in cardiovascular disease patients during the COVID-19 lockdown in the Netherlands; a longitudinal cohort study

Mr B. van Bakel (Nijmegen, NL)

Abstract Slides Video

Presentation thumbnail

Lifestyle management and compliance in coronary patients: The gender gap. Results from the ESC EORP EUROASPIRE V survey

Mr P. Vynckier (Ghent, BE)

Abstract Slides Video

Presentation thumbnail

Cardiac rehabilitation and all-cause mortality in patients with heart failure: A retrospective cohort study

Doctor B. Buckley (Liverpool, GB)

Abstract Slides Video

Presentation thumbnail

Effectiveness of cardiac telerehabilitation with relapse prevention compared to centre-based cardiac rehabilitation: results from the SmartCare-CAD randomised controlled trial

Mr R. Brouwers (Eindhoven, NL)

Abstract Slides Video

Presentation thumbnail

Low skeletal muscle density combined with muscle dysfunction predicts adverse events after adult cardiovascular surgery

Mr M. Yamashita (Sagamihara, JP)

Abstract Slides Video

Access the full session

Session thumbnail

Young Investigators Award Secondary Prevention and Rehabilitation

The Event

ESC Preventive Cardiology 2021

17 April 2021 09:12 CET

You may be interested in

Webinar

Prevention of heart failure in diabetic patients at population level

Congress Session

Diabetes, obesity, and heart failure

Webinar

Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources